SCHOTT strengthens its position in the Asian pharmaceutical market
First fully automated production line for pharmaceutical packaging sets new standards in India
With the opening of a high-tech facility in India, SCHOTT continues to strengthen its strategic position in the Asian pharmaceutical market. As with the existing production plant in the city of Daman, SCHOTT KAISHA, a joint venture in which SCHOTT holds a 50% stake, will run the new production facility, located in Jambusar in the western state of Gujarat.
The new plant will allow SCHOTT to increase production by 50%, bringing total annual output to about two billion ampoules, vials, syringes, and cartridges. According to various studies, the Indian pharmaceutical industry is growing by 14 to 17 percent a year, primarily due to strong domestic demand from a rising Indian middle class seeking better medical care.
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.